Page last updated: 2024-09-05

2'-hydroxyflavanone and Carcinoma, Anaplastic

2'-hydroxyflavanone has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hofman, J; Malcekova, B; Novotna, E; Skarka, A; Wsol, V1

Other Studies

1 other study(ies) available for 2'-hydroxyflavanone and Carcinoma, Anaplastic

ArticleYear
Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Toxicology and applied pharmacology, 2014, Aug-01, Volume: 278, Issue:3

    Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anthracyclines; Antibiotics, Antineoplastic; Biotransformation; Carcinoma; Cell Line, Tumor; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Flavanones; Humans; Hydroxyprostaglandin Dehydrogenases; Idarubicin; Kinetics; Neoplasm Proteins; Oxidation-Reduction; Recombinant Proteins

2014